Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Commented On News and Future Directions
Immunophenotyping Separates MS Subtypes by Neuroinflammation
Ganciclovir Inhibits Neuroinflammation in Mouse Model of MS
Obstructive Sleep Apnea Contributes to MS Fatigue
Tears Yield Possible MS Biomarker
MS Patient, Ph.D.: Is 23andMe Doing It Right?
3-Year Average Delay in Identifying SPMS Transition
Exploiting the EBV-MS Link to Quell Secondary Progressive Disease
MS Patient, Ph.D.: MS and Vitamin D: What’s a Patient to Do?
Serum Vitamin D Levels Predict Severity of MS
MS Patient, Ph.D.: That’s Not PPMS? Well, It’s My PPMS
FDA's Denial of Alemtuzumab Stirs Controversy
MS Patient, Ph.D.: Is It Too Early to Get Excited About the BCG Vaccine?
Genomic Double Play
MS Patient, Ph.D.: Greetings From Limbo Land
Cheap Vaccine Slows MS Progression
MS Patient, Ph.D.: First Trip to the Frontline
MS Patient, Ph.D.
Study Reveals New Facets of NMO Pathophysiology
New Pathogen Linked to MS
Genome-wide Study Brings MS Landscape Into Sharper Focus
Debate: Do Physicians Rate the Risk of Disabling MS Less Than the Risk of Effective Treatment?
The Many Faces of B Cells
Phase 1 Trial of Stem Cells Begins in MS
Harnessing Epitope Spreading to Treat MS
MS-SMART Trial for Secondary Progressive MS Announced
Pages
« first
‹ previous
1
2
3
4
next ›
last »
Pages